Kirkland & Ellis advised AIM ImmunoTech on the deal. AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics...
-
Follow Us
-
Search
- North America
September 23, 20264Ready Capital Completes $225 Million Senior Secured Notes Offering
September 23, 20264Steve Cohen Acquires WTGL New York Team
- Latin America
September 22, 20264LIAG Argentina Group Secures Two US$20 Million Loans from Banco Galicia
September 22, 20264NCB Financial Group Completes Intra-Group Sale of Cayman Banking Subsidiaries
September 22, 20264Cemig Geração e Transmissão Completes R$1 Billion Debenture Offering
- Europe
September 23, 20264Raiffeisen Schweiz Genossenschaft Completes EUR 500 Million Fixed-to-Fixed Rate Bond Issuance Due 2034
September 23, 20264Chiltern Railways Transferred to Public Ownership
September 23, 20264Ed.ai Secures €5 Million Seed Funding Round
- Africa
September 22, 20264Al Baraka Bank Egypt Launches Share Swap Offer for AT Lease
September 21, 20264Genser Energy Secures EUR456 Million Syndicated Facilities for West African Expansion
September 10, 20264Financing Secured for Boujdour II Wind Farm in Morocco
- Middle East
September 18, 20264$100 Million Trade Finance Facility Agreement Reached Between BADEA and The Gambia Government
September 11, 20264ACDIMA Sells 20% Stake in SPIMACO Through Block Trade and Accelerated Bookbuilding
August 11, 20264Zenity Secures $125 Million Series C Funding to Drive AI Agent Security Expansion
- Asia & Pacific
- Editorials
September 23, 20264Finn Dixon & Herling Names Claire Stevens as Chair of Investment Management Practice
September 22, 20264Quinn Emanuel adds London head to Mariana Dam Case
September 18, 20264Ellenoff Grossman & Schole Welcomes Evelyn Louie-Nam as new Chief Financial Officer
- In & Out
September 23, 20264Former DOJ Leader Mark Cipolletti Joins Honigman’s Investigations and White Collar Defense Practice in DC
September 23, 20264Gibson Dunn Adds Fund Finance Lawyer Andrew Hogan in New York
September 23, 20264Norton Rose Fulbright Appoints Healthcare-Focused Litigation Partner Tim Ribelin in Austin